Cover of Independent advocacy in healthcare for children and young people

Independent advocacy in healthcare for children and young people

Babies, children and young people’s experience of healthcare

Evidence review I

NICE Guideline, No. 204

Authors

.

London: National Institute for Health and Care Excellence (NICE); .
ISBN-13: 978-1-4731-4231-2
Copyright © NICE 2021.

Independent advocacy in healthcare for children and young people

Review question

How can the views of babies, children and young people be best represented by independent advocates?

Introduction

The Care Act 2014 and Mental Health Act 1983/2007 place a duty on UK councils to provide an independent advocate for a baby, child or young person who has substantial difficulties being involved in their own healthcare or who may not have an appropriate person to represent them. In addition to this, independent advocates may be used in healthcare situations where babies, children and young people cannot agree with their parents or healthcare professionals over a healthcare decision, or where it is not appropriate for their parents or carers to represent them.

Independent advocates provide information and an opportunity for children and young people to express their wishes and concerns about healthcare, with the reassurance that the advocates are independent from their healthcare providers and that these discussions will not impact the care they receive. Furthermore, the independent advocate develops a trusting relationship with the child or young person, empowering them to make decisions, and acts as an objective supporter. However, independent advocates can be obtained from a range of providers, with individual advocates having different competencies and experience, and there may be variation in practice and quality of support.

The aim of this review is to determine how children and young people can be best represented by independent advocates.

Summary of the protocol

See Table 1 for a summary of the population, phenomenon of interest and primary outcome characteristics of this review.

Table 1. Summary of the protocol.

Table 1

Summary of the protocol.

For further details see the review protocol in appendix A.

Methods and process

This evidence review was developed using the methods and process described in Developing NICE guidelines: the manual. Methods for this review question are described in the review protocol in appendix A and the methods supplement.

Clinical evidence

Included studies

This was a qualitative review with the aim of:

  • Understanding how babies, children and young people prefer to be supported by independent advocates in healthcare.

A systematic review of the literature was conducted using a combined search but no studies were identified which were applicable to this review question.

See the literature search strategy in appendix B and study selection flow chart in appendix C.

Excluded studies

Studies not included in this review are listed, and reasons for their exclusion are provided in appendix K.

Summary of studies included in the evidence review

No studies were identified which were applicable to this review question (and so there are no evidence tables in appendix D). No meta-analysis was undertaken for this review (and so there are no forest plots in appendix E).

Quality assessment of studies included in the evidence review

No studies were identified which were applicable to this review question (and so there are no evidence profiles in appendix F).

Evidence from reference groups and focus groups

The children and young people’s reference groups and focus groups provided additional evidence for this review. A summary of the evidence is presented in Table 2.

Table 2. Summary of the evidence from reference groups and focus groups.

Table 2

Summary of the evidence from reference groups and focus groups.

See the full evidence summary in appendix M.

Evidence from national surveys

The grey literature review of national surveys provided additional evidence for this review. A summary of the evidence is presented in Table 3.

Table 3. Summary of the evidence from national surveys.

Table 3

Summary of the evidence from national surveys.

See the evidence summary in appendix N.

Evidence from an expert witness

An expert witness (an independent advocate) provided additional evidence for this review.

See the evidence summary in appendix O.

There was no evidence available from a child or young person with experience of using advocacy services.

Economic evidence

Included studies

A systematic review of the economic literature was conducted but no studies were identified which were applicable to this review question. A single economic search was undertaken for all topics included in the scope of this guideline. See supplementary material 6 for details.

Excluded studies

Economic studies not included in this review are listed, and reasons for their exclusion are provided in appendix K.

Summary of studies included in the economic evidence review

No studies were identified which were applicable to this review question.

Economic model

No economic modelling was undertaken for this review because the committee agreed that other topics were higher priorities for economic evaluation.

The committee’s discussion of the evidence

Interpreting the evidence
The outcomes that matter most

This review focused on how babies, children and young people feel that their views and needs can be best represented by independent advocates. To adequately cover this issue, the review was designed to include qualitative data. Due to this, the committee could not specify in advance what data might be located in the literature but they did identify the following main themes in advance to guide the review:

  • Access to records of healthcare staff discussions
  • Adequate training for independent advocates including knowledge about developmentally-appropriate approaches
  • Appeal to, or use of, advocacy groups
  • Availability and accessibility of appropriate advocacy services
  • Awareness of independent advocate services
  • Encouraging and supporting self-advocacy when possible
  • Sensitivity and responsiveness of independent advocate to feedback from child or young person
  • Views on timing of support provided from the independent advocate, establishing views regarding where and when advocacy is beneficial, including continuity of support

No studies were identified in the literature for this review. However, the expert witness addressed most of the themes identified by the committee, except the use of developmentally-appropriate training and the use of advocacy groups.

The quality of the evidence

No studies were identified which were applicable to this review question.

Benefits and harms

The committee were aware of the legal requirement for UK Councils to provide an independent advocate for any person under 18 who has been detained under the Mental Health Act 183, or for a looked after child or young person under the terms of the Care Act 2014 and the Mental Capacity Act 2005. Therefore, the committee made a recommendation to inform eligible children and young people that they could have an independent advocate to support them. However, access to independent advocates for children and young people who do not meet the criteria specified in these pieces of legislation depends on the local commissioning arrangements and, despite it not being a legal requirement, the committee were aware that independent advocates could provide invaluable support to babies, children or young people who did not have parents or carers or another professional who could adequately advocate for them. The committee also made a recommendation for commissioners to consider independent advocacy for a wider population of children and young people who would not be eligible under statutory provision, to protect their interests and wishes and to contribute towards a positive healthcare experience.

The testimony of the expert witness included information on the role of an independent advocate in the mental health setting, how children and young people are able to access them, and the independent nature of the role. The committee discussed that children and young people often are not aware of this service and do not know how an advocate could support them.. Therefore, the committee made a recommendation to ensure that children and young people are provided with this information. The committee agreed this information should also include the fact that an independent advocate is separate from their healthcare team, and any concerns they may raise will not affect their healthcare. If a child or young person decide that they would like to meet with an independent advocate, the committee made a recommendation that healthcare staff should support them.

The committee discussed that the period when an independent advocate might be needed can be a stressful time for children and young people. The expert witness described the importance of building a trusting relationship with children and young people, allowing a rapport to developed. Confidentiality is an important aspect of this trust, but the expert witness reported that the limits of this confidentiality (and when it will be broken) must also be explained. In order to best explain healthcare processes and translate medical language, independent advocates need to be familiar with medical terminology and with relevant healthcare systems. All these attributes are core to an independent advocate being able to support children and young people in their healthcare. Therefore, the committee made a recommendation describing the essential competencies of an independent advocate. Additionally, the expert witness and the committee discussed the importance of understanding the role of an independent advocate in empowering children and young people to make decisions, rather than making decisions on their behalf. This aspect of the role can sometimes be misconstrued by both healthcare staff and the public. Therefore, the committee made a recommendation clarifying this supportive role of the independent advocate.

The expert witness reported the use of feedback within the advocacy service. The committee discussed the importance of gaining views on service provision directly from children and young people, as there are aspects to paediatric independent advocacy that will not apply to adult advocacy and vice versa. Therefore, the committee made a recommendation to include a review process to make sure the advocacy service is good quality and is working well for children and young people.

In addition to the evidence from the expert witness, there was a limited amount of evidence presented from the grey literature review of national surveys and reference groups (age 11 to 14 years) on the meaning of and use of advocates. The committee agreed that the evidence from the reference group reinforced the testimony from the expert witness about the need to build trusting relationships with children and young people, and to empower them to make their healthcare decisions rather than having decisions made for them. The evidence from the national surveys showed that some young people may have found an advocate useful to help them to raise concerns about their healthcare.

The committee also discussed the potential harms of independent advocacy, most of which relate to the competency and experience of the independent advocate. One of these was the chance of information being presented to children and young people in either a misleading or misrepresentative manner, including what options are available to them. Both the expert witness and committee members with experience of independent advocates agreed that advocacy on behalf of children and young people required a different set of skills than advocating for adults. If a child was allocated an advocate experienced only in advocating for adults, this could be detrimental to the child or young person. Lack of time was also a potential area of harm, as independent advocates needed time to work with children and young people, and insufficient time may lead to sub-optimal advocacy.

All of these concerns might lead to poor representation of a child or young person’s views or insensitivity when talking about past experiences. This will affect both the immediate consultation and perhaps affect the child or young person’s views of independent advocates in the future.

As there was no evidence from the systematic review of the literature for this review the committee agreed that research was needed in this area and they made a research recommendation.

Cost effectiveness and resource use

No economic studies were identified which were applicable to this review question. The committee discussed that there may be some resource implications associated with a wider cohort of children and young people having access to an independent advocate, but that the extension of the service suggested in their recommendations would only apply to children or young people who had no one else to support them (neither parent nor carer nor another professional such as a social worker) and so was not likely to include a very large number of children. The committee agreed that for the majority of children and young people who would require such service, it is already a legal requirement under the Mental Health Act 1983, the Care Act 2014 and the Mental Capacity Act 2005. The recommendations in this area may make more children and young people aware of such services and there may be a greater uptake of independent advocate services which may have a financial impact for the NHS. The committee also discussed that there may be some resource implications in terms of healthcare professionals’ time in facilitating access to an independent advocate such as providing support in the initial contact and subsequent meetings. All the other recommendations in this area reflect current practice for most services and would have only modest resource implications, if any, which are justifiable as such care is likely to lead to improvements in children and young people’s experience of healthcare.

Recommendations supported by this evidence review

This evidence review supports recommendations 1.5.18 to 1.5.24 and the research recommendation on independent advocates.

References

    No studies were identified which were applicable to this review question.

Appendices

Appendix D. Clinical evidence tables

Evidence tables for review question: How can the views of babies, children and young people be best represented by independent advocates?

No evidence was identified which was applicable to this review question.

Appendix E. Forest plots

Forest plots for review question: How can the views of babies, children and young people be best represented by independent advocates?

No meta-analysis was conducted for this review question and so there are no forest plots.

Appendix F. GRADE-CERQual tables

GRADE-CERQual tables for review question: How can the views of babies, children and young people be best represented by independent advocates?

No evidence was identified which was applicable to this review question.

Appendix G. Economic evidence study selection

Economic evidence study selection for review question: How can the views of babies, children and young people be best represented by independent advocates?

No economic evidence was identified which was applicable to this review question.

Appendix H. Economic evidence tables

Economic evidence tables for review question: How can the views of babies, children and young people be best represented by independent advocates?

No evidence was identified which was applicable to this review question.

Appendix I. Economic evidence profiles

Economic evidence profiles for review question: How can the views of babies, children and young people be best represented by independent advocates?

No economic evidence was identified which was applicable to this review question.

Appendix J. Economic analysis

Economic evidence analysis for review question: How can the views of babies, children and young people be best represented by independent advocates?

No economic analysis was conducted for this review question.

Appendix K. Excluded studies

Excluded studies for review question: How can the views of babies, children and young people be best represented by independent advocates?

Clinical studies
Table 5. Excluded studies and reasons for their exclusion.

Table 5

Excluded studies and reasons for their exclusion.

Economic studies

No economic evidence was identified for this review. See supplementary material 6 for details.